Sepimostat dimethanesulfonate (FUT-187) exhibits significant neuroprotective effects by antagonizing the NR2B subunit of N-methyl-D-aspartate (NMDA) receptors at the ifenprodil binding site; it has been shown to provide neuroprotection in vivo following intravitreal injection (1 to 100 nmol/eye) in male Sprague Dawley rats.